STOCKHOLM, SWEDEN, May 13, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has reached a new milestone with 10,000 patients treated with the innovative nanosynthetic bone graft OssDsign Catalyst on the US market. OssDsign Catalyst is a nanosynthetic bone graft that demonstrates rapid and robust bone formation, even in poorly vascularized environments. Launched in the US in August 2021, OssDsign Catalyst has since achieved significant success in the Amer ...

Reported Net Product Revenues of $20.9 million for the first quarter of 2025, a year-over-year increase of approximately 8% National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Neuroblastoma updated to include naxitamab-gqgk (DANYELZA®)Dosed first patient in Phase 1 clinical trial evaluating CD38-SADA pretargeted radioimmunotherapy in patients with Relapsed/Refractory non-Hodgkin Lymphoma (Trial 1201)The Company to host virtual Radiopharmaceutical R&D update discussing ...

WILLIAMSBURG, Va., May 13, 2025 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO), (“Sotherly” or the “Company”), a self-managed and self-administered lodging real estate investment trust (a “REIT”), today reported its consolidated results for the first quarter ended March 31, 2025. The Company’s results include the following*: Three Months Ended March 31, 2025 March 31, 2024 ($ in thousands except per share data) Total revenues$48,312 $46,548 <td style="text-align: left ; vertical-align: midd ...

Data also demonstrate significantly lower rates of postoperative reflux and decreased incidence of de novo gastroesophageal reflux disease (GERD) without affecting total weight loss at 1-year*, and shorter average hospital length of stay (LOS) associated with use of the Titan SGS™ Stapler compared with multi-fire staplers1 WAYNE, Pa., May 13, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the publication of a new retrospective a ...

Til Nasdaq Copenhagen A/S 13. maj 2025 Nykredit Realkredit A/S: Ledende medarbejdere og disses nærtstående transaktioner Indberetning og offentliggørelse af ledende medarbejdere og disses nærtstående transaktioner med Nykredit Realkredit A/S værdipapirer i henhold til markedsmisbrugsforordningens artikel 19. Se vedhæftede fil. Attachment 2980675_R_Rapporter ...

Core Insights - Fennec Pharmaceuticals reported first quarter 2025 total net revenues of $8.8 million, representing an 18% increase year over year from $7.4 million in the first quarter of 2024 [1][5][10] - The company has successfully launched PEDMARQSI in Germany and the United Kingdom, enhancing access to its product for cancer patients at risk of hearing loss [1][6][29] - The revamped Fennec HEARS™ patient support program aims to improve the experience for adolescent and young adult cancer patients [2][6] Financial Results - Net product sales for the first quarter of 2025 were approximately $8.8 million, up from $7.4 million in the same period last year [5][10] - Total revenue for the first quarter was $8.8 million, with no licensing revenue recorded compared to $17.96 million in the first quarter of 2024 [10] - Operating expenses totaled $9.56 million, down from $11.63 million in the previous year, with selling and marketing expenses decreasing to $2.95 million from $5.21 million [11][10] Business Highlights - The company has strengthened its segmentation model and data-driven target lists, leading to the addition of multiple new accounts across academic and community providers [6][7] - The commercial launch of PEDMARQSI in Europe marks a significant step in expanding access to the product [6][29] - Fennec will participate in the ASCO 2025 Annual Meeting and other investor conferences, indicating ongoing engagement with the medical and investment communities [6][4] Upcoming Events - Fennec will host a conference call on May 13, 2025, at 8:30 a.m. ET to discuss its financial results and business updates [1][8] - The Annual General Meeting is scheduled for June 3, 2025, in New York, providing an opportunity for shareholder engagement [6][4]

Core Viewpoint - High Arctic Energy Services Inc. reported a solid start to 2025 despite challenges in well completion rates in Canada due to market uncertainty and customer consolidation events [2][3]. Financial Performance - Revenue from continuing operations for Q1 2025 was $2,335 thousand, a decrease of 22% compared to $2,988 thousand in Q1 2024 [7][9]. - Adjusted EBITDA from continuing operations was $504 thousand in Q1 2025, significantly up from $92 thousand in Q1 2024, representing 22% of revenue [7][9]. - The oilfield services operating margin percentage improved to 53.1% in Q1 2025 from 49.4% in Q1 2024, despite a decrease in revenue [7][9]. - General and administrative expenses were reduced by 59% compared to Q1 2024, contributing to a decrease in operating loss from $1,070 thousand in Q1 2024 to $128 thousand in Q1 2025 [7][14]. Operational Highlights - The company maintained operational excellence with recordable incident-free work and a focus on safety [7]. - The integration of Delta Rental Services is delivering financial performance in line with expectations, with anticipated upside as gas well completion rates increase [3][20]. - The equity investment in Team Snubbing remained stable at $7.4 million as of March 31, 2025, with positive net income contributions from its financial results [7][9]. Liquidity and Capital Resources - As of March 31, 2025, working capital was $3,199 thousand, an increase from $2,692 thousand as of December 31, 2024, primarily due to positive EBITDA and the settlement of contingent consideration in common shares [18][19]. - Cash flow from continuing operations was $31 thousand in Q1 2025, down from $271 thousand in Q1 2024, while funds flow from operating activities increased to $495 thousand from $197 thousand [12][13]. Strategic Objectives and Outlook - The company aims to grow core businesses through selective investments, manage operating costs, and execute accretive acquisitions to drive shareholder value [7][20]. - The outlook for 2025 is influenced by the performance of the investment in Team Snubbing, with total assets related to this investment at $9.8 million [25][26]. - Positive developments in Canadian infrastructure, such as the completion of the Trans Mountain pipeline expansion and expectations for LNG exports, are expected to support long-term fundamentals for the upstream energy service business [23][24].

Core Viewpoint - Qifu Technology, Inc. will hold its annual general meeting (AGM) on June 30, 2025, to discuss several key resolutions including a name change and re-appointment of auditors [1][4]. Group 1: AGM Details - The AGM is scheduled for June 30, 2025, at 10:00 a.m. Beijing time, at Lujiazui Finance Plaza, Shanghai [1]. - The record date for Class A ordinary shares is set for May 27, 2025, Hong Kong time, allowing holders to attend and vote at the AGM [2]. - Holders of American Depositary Shares (ADSs) must provide voting instructions to The Bank of New York Mellon to exercise their voting rights [3]. Group 2: Proposed Resolutions - Proposed changes at the AGM include changing the company's English name from "Qifu Technology, Inc." to "Qfin Holdings, Inc." [1]. - The company plans to adopt an amended and restated memorandum and articles of association [1]. - Deloitte Touche Tohmatsu Certified Public Accountants LLP is proposed for re-appointment as the auditor until the next AGM [1]. - Mr. Xiangge Liu is proposed for re-election as a director of the company [1]. Group 3: Company Overview - Qifu Technology is a leading AI-empowered Credit-Tech platform in China, providing technology services throughout the loan lifecycle [5]. - The company utilizes machine learning models and data analytics to enhance credit service accessibility for consumers and SMEs [5].

SAN JUAN CAPISTRANO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it will participate in the 2025 RBC Capital Markets Global Healthcare Conference on May 20, 2025. Barry Port, Chief Executive Officer; Chad Keetch, Chief In ...

European commercial property values rose for the third consecutive quarterLONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, today released its Q1 2025 Pan-European dataset analysis on European property market valuation trends. Each quarter, Altus Group centralizes and aggregates CRE valuation data for the European market, pulling insights into the factors driving commercial property valuations. The Q1 2025 ag ...